NCT04890444

China Adrenal Disease Registry

China Adrenal Disease Registry Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Shanghai Jiao Tong University School of Medicine · Academic / Other
• Sex: All
• Age: 16 Years – 75 Years
• Healthy volunteers: —

Summary

Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.

Detailed description

In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE is committed to creating an online and offline integrated solution for adrenal disease, and for the entire spectrum of adrenal disease, to achieve a more convenient and precise model of care for patients, aiming to establish a platform with diagnosis and treatment of adrenal disease and their long-term follow-up. It allows the application and evaluation of treatment strategies at these centers.

Conditions

• Cushing Syndrome
• Aldosteronism
• Hypoadrenalism
• Congenital Adrenal Hyperplasia
• Adrenal Adenoma
• Adrenal Incidentaloma
• Adrenal Carcinoma
• Pheochromocytoma

Timeline

• Start date: 2021-06-01
• Primary completion: 2026-04-30
• Completion: 2026-04-30
• First posted: 2021-05-18
• Last updated: 2022-02-14

Locations

1 site across 1 country: China